Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy.

Ouedraogo DE, Makinson A, Vendrell JP, Casanova ML, Nagot N, Cezar R, Bollore K, Al Taaba Y, Foulongne V, Badiou S, Viljoen J, Reynes J, Van de Perre P, Tuaillon E.

Blood. 2013 Oct 24;122(17):3030-3. doi: 10.1182/blood-2012-12-470393. Epub 2013 Aug 12.

PMID:
23940281
[PubMed - indexed for MEDLINE]
2.

HIV, EBV, and monoclonal gammopathy.

Mailankody S, Landgren O.

Blood. 2013 Oct 24;122(17):2924-5. doi: 10.1182/blood-2013-08-522508.

PMID:
24159162
[PubMed - indexed for MEDLINE]
3.

Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.

Petrara MR, Cattelan AM, Zanchetta M, Sasset L, Freguja R, Gianesin K, Cecchetto MG, Carmona F, De Rossi A.

J Clin Virol. 2012 Mar;53(3):195-200. doi: 10.1016/j.jcv.2011.12.013. Epub 2011 Dec 30.

PMID:
22209290
[PubMed - indexed for MEDLINE]
4.

Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.

O'Sullivan CE, Peng R, Cole KS, Montelaro RC, Sturgeon T, Jenson HB, Ling PD.

J Med Virol. 2002 Jul;67(3):320-6.

PMID:
12116021
[PubMed - indexed for MEDLINE]
5.

Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy.

Righetti E, Ballon G, Ometto L, Cattelan AM, Menin C, Zanchetta M, Chieco-Bianchi L, De Rossi A.

AIDS. 2002 Jan 4;16(1):63-73.

PMID:
11741164
[PubMed - indexed for MEDLINE]
6.

Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.

de Lastours V, LeGoff J, Brière J, Agbalika F, Boulet T, Lévy Y, Simon F, Aboulker JP, Molina JM.

HIV Med. 2014 Jan;15(1):23-9. doi: 10.1111/hiv.12077. Epub 2013 Sep 6.

PMID:
24007426
[PubMed - indexed for MEDLINE]
7.

High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.

Stevens SJ, Blank BS, Smits PH, Meenhorst PL, Middeldorp JM.

AIDS. 2002 May 3;16(7):993-1001.

PMID:
11953465
[PubMed - indexed for MEDLINE]
8.

Changes in blood B cell phenotypes and Epstein-Barr virus load in chronically human immunodeficiency virus–infected patients before and after antiretroviral therapy.

Richard Y, Amiel C, Jeantils V, Mestivier D, Portier A, Dhello G, Feuillard J, Creidy R, Nicolas JC, Raphael M.

J Infect Dis. 2010 Nov 1;202(9):1424-34. doi: 10.1086/656479.

PMID:
20874514
[PubMed - indexed for MEDLINE]
Free Article
9.

Effects of long-term use of antiretroviral therapy on the prevalence of oral Epstein-Barr virus.

Amornthatree K, Sriplung H, Mitarnun W, Nittayananta W.

J Oral Pathol Med. 2012 Mar;41(3):249-54. doi: 10.1111/j.1600-0714.2011.01089.x. Epub 2011 Oct 8.

PMID:
21981060
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy.

Burighel N, Ghezzi S, Nozza S, Del Bianco P, Lazzarin A, Tambussi G, Poli G, De Rossi A.

Haematologica. 2006 Feb;91(2):244-7.

PMID:
16461311
[PubMed - indexed for MEDLINE]
Free Article
11.

Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.

Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankalé JL, Ekong E, Murphy R, Kanki P, Thio CL.

Clin Infect Dis. 2009 Oct 15;49(8):1268-73. doi: 10.1086/605675.

PMID:
19772386
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus.

Giron LB, Ramos da Silva S, Barbosa AN, Monteiro de Barros Almeida RA, Rosário de Souza Ld, Elgui de Oliveira D.

J Med Virol. 2013 Dec;85(12):2110-8. doi: 10.1002/jmv.23722. Epub 2013 Sep 6.

PMID:
24014234
[PubMed - indexed for MEDLINE]
13.

Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection.

Legoff J, Amiel C, Calisonni O, Fromentin D, Rajoely B, Abuaf N, Tartour E, Rozenbaum W, Bélec L, Nicolas JC.

J Clin Immunol. 2004 Mar;24(2):125-34.

PMID:
15024179
[PubMed - indexed for MEDLINE]
14.

Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.

Ling PD, Vilchez RA, Keitel WA, Poston DG, Peng RS, White ZS, Visnegarwala F, Lewis DE, Butel JS.

Clin Infect Dis. 2003 Nov 1;37(9):1244-9. Epub 2003 Sep 23.

PMID:
14557970
[PubMed - indexed for MEDLINE]
Free Article
15.

Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.

Alatrakchi N, Duvivier C, Costagliola D, Samri A, Marcelin AG, Kamkamidze G, Astriti M, Agher R, Calvez V, Autran B, Katlama C.

AIDS. 2005 Jan 3;19(1):25-33.

PMID:
15627030
[PubMed - indexed for MEDLINE]
16.

Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.

Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW, Middeldorp JM.

AIDS. 2007 Oct 18;21(16):2141-9.

PMID:
18090040
[PubMed - indexed for MEDLINE]
17.

Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.

Piriou E, Jansen CA, van Dort K, De Cuyper I, Nanlohy NM, Lange JM, van Oers MH, Miedema F, van Baarle D.

J Immunol. 2005 Aug 1;175(3):2010-7.

PMID:
16034146
[PubMed - indexed for MEDLINE]
Free Article
18.

Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients.

Jacobson MA, Ditmer DP, Sinclair E, Martin JN, Deeks SG, Hunt P, Mocarski ES, Shiboski C.

PLoS One. 2009;4(4):e5277. doi: 10.1371/journal.pone.0005277. Epub 2009 Apr 17.

PMID:
19381272
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.

Antiretroviral Therapy Cohort Collaboration, Zwahlen M, Harris R, May M, Hogg R, Costagliola D, de Wolf F, Gill J, Fätkenheuer G, Lewden C, Saag M, Staszewski S, d'Arminio Monforte A, Casabona J, Lampe F, Justice A, von Wyl V, Egger M.

Int J Epidemiol. 2009 Dec;38(6):1624-33. doi: 10.1093/ije/dyp306. Epub 2009 Oct 9.

PMID:
19820106
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.

Challine D, Buisson M, Cadilhac M, Germanidis G, Joab I, Eliaszewicz M, Caumes E, Flahault A, Fillet AM, Pawlotsky JM, Seigneurin JM.

J Med Virol. 2002 Aug;67(4):510-5.

PMID:
12115996
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk